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Summary
 
The T cell repertoire is shaped by positive and negative selection of thymocytes through the
interaction of 
 
a/b
 
-T cell receptors (TCR) with self-peptides bound to self-major histocompat-
ibility complex (MHC) molecules. However, the involvement of specific TCR-peptide con-
tacts in positive selection remains unclear. By fixing TCR-
 
b
 
 chains with a single rearranged
TCR-
 
b
 
 irrelevant to the selecting ligand, we show here that T cells selected to mature on a
single MHC–peptide complex express highly restricted TCR-
 
a
 
 chains in terms of V
 
a
 
 usage
and amino acid residue of their CDR3 loops, whereas such restriction was not observed with
those selected by the same MHC with diverse sets of self-peptides including this peptide. Thus,
we visualized the TCR structure required to survive positive selection directed by this single
ligand. Our findings provide definitive evidence that specific recognition of self-peptides by
TCR could be involved in positive selection of thymocytes.
Key words: positive selection • single major histocompatibility complex–peptide complex • 
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A
 
lthough the diversity of 
 
a/b
 
-TCR theoretically reaches
10
 
15 
 
by random rearrangement of five gene segments
(V
 
a
 
, J
 
a
 
, V
 
b
 
, D
 
b
 
, and J
 
b
 
) and random nucleotide addition (1),
mature T cells express highly selected TCR in that they
exhibit tolerance to self-antigenic peptides and restriction by
self-MHC molecules. This mainly results from two recipro-
cal selection processes, positive and negative selection, acting
during T cell development in the thymus. Positive selection
is the process that induces differentiation of CD4
 
1
 
CD8
 
1
 
immature thymocytes into CD4
 
2
 
CD8
 
1
 
 or CD4
 
1
 
CD8
 
2
 
mature thymocytes that mount immune response on for-
eign antigenic peptides bound to self-MHC molecules in
the periphery, only when their TCR recognize self-MHC
class I or class II molecules in the thymic environment (2–
7). On the other hand, negative selection is the process that
eliminates immature thymocytes bearing TCR specific for
self-peptides bound to self-MHC molecules (8–12).
Although it is widely accepted that self-peptides play a
central role in negative selection, the role of self-peptides in
positive selection has been the subject of considerable de-
bate (13, 14). This issue was first directly addressed for pos-
itive selection of CD8
 
1
 
 T cells using fetal thymic organ
cultures derived from mutant mouse strains where a partic-
ular MHC class I–peptide complex is expressed by exoge-
nously adding a given peptide to the culture (15–19). More
recently, several groups developed in vivo experimental
systems focusing on the role of self-peptides in positive se-
lection of CD4
 
1
 
 T cells, by creating mouse strains that ex-
press MHC class II molecules predominantly occupied
with a single peptide (20–24). The conclusions deduced
from these in vitro and in vivo studies for positive selection
of CD8
 
1
 
 or CD4
 
1
 
 T cells are largely in agreement:
whereas limited numbers of self-peptides bound to a given
MHC molecule promoted the positive selection of T cells
expressing diverse sets of TCR-
 
a/b
 
 with no obvious struc-
tural features, this complex could not be a positively select-
ing ligand for T cells expressing a particular transgenic
TCR-
 
a/b
 
 that is selected to mature on the same MHC
molecule with a normal array of self-peptides (25–28). This
might reflect the weak but specific recognition of selecting
peptides by TCR-
 
a/b
 
 in positive selection. However, ex-
periments using TCR-
 
a/b
 
 transgenic mice could not ex-
clude the possibility that side chains of the peptides inter-
fere with the interaction of the analyzed TCR-
 
a/b
 
 with
MHC molecule that would be essentially required for posi-
tive selection (29). In this respect, it would be important to
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assess whether specific TCR–peptide contacts are involved
in positive selection, under physiological conditions where
developing thymocytes express diverse sets of TCR-
 
a/b
 
.
Sant’Angelo et al. (30) recently addressed this issue by ana-
lyzing a particular V
 
a
 
-J
 
a
 
 segment in mice lacking H-2M
(H-2M
 
0/0
 
)
 
1
 
 that catalyzes the dissociation of invariant
chain–derived class II–associated peptide, CLIP, in the
presence of a single rearranged TCR-
 
b
 
 chain. Although
this study has shown that alternation of self-peptide reper-
toire affects CDR3 length of the selected TCR-
 
a
 
 reper-
toire, no remarkable bias for amino acid composition of
their CDR3 loops could be deduced. This might be a gen-
eral feature of a positively selected T cell repertoire. Alter-
natively, this may be the result of the heterogeneity of se-
lecting peptides, because it has been shown that peptides
other than CLIP are bound to I-A
 
b
 
 molecules and contrib-
ute to the positive selection of CD4
 
1
 
 thymocytes in
H-2M
 
0/0
 
 mice (26). In addition, it remains unclear from
this study whether self-peptides involved in positive selec-
tion would affect variable gene segments of the selected
TCR repertoire and this needs to be known if one is to
better understand TCR-MHC-peptide interaction in posi-
tive selection process.
To clarify specific TCR–peptide contacts in positive se-
lection, we analyzed the structure of TCR-
 
a
 
 chains ex-
pressed on CD4
 
1
 
CD8
 
2
 
 thymocytes selected to mature on
a single ligand, I-A
 
b
 
 molecule covalently bound to E
 
a
 
-
derived peptide (E
 
a
 
52-68), in the presence of a single rear-
ranged TCR-
 
b
 
 chain with irrelevant specificity for this
ligand. Since positive selection is thought to be mediated
through low affinity interaction of TCR-
 
a/b
 
 with MHC–
peptide ligands (31), introduction of the TCR-
 
b
 
 chain ir-
relevant to I-A
 
b
 
–E
 
a
 
52-68 complex would give us a better
chance to reveal structural features of the associated TCR-
 
a
 
chains selected by this ligand. Therefore, we have selected
the 2B4 TCR-
 
b
 
 chain derived from the TCR-
 
a/b
 
 specific
for moth cytochrome c peptide bound to I-E
 
k
 
 or I-E
 
b
 
 mol-
ecules (32). By comparing the TCR-
 
a
 
 repertoire shaped
by I-A
 
b
 
–E
 
a
 
52-68 complex with that by I-A
 
b
 
 molecules
with a normal array of self-peptides, including E
 
a
 
52-68, in
the presence 2B4 TCR-
 
b
 
 chain, we demonstrate here that
expression of TCR-
 
a
 
 chains with both particular V
 
a
 
 seg-
ments and amino acid residue in their CDR3 loops is re-
quired to survive positive selection by this single ligand.
These findings provide definitive evidence that specific
TCR–peptide interaction could be involved in the positive
selection of thymocytes.
 
Materials and Methods
 
Mice.
 
B2L mice that express the I-A
 
b
 
b
 
 chain covalently
bound to E
 
a
 
52-68 but lack endogenous I-A
 
b
 
b
 
 and invariant
chains (B2L DKO) have been described (24). B2L DKO mice
were crossed with 
 
b
 
2-microglobulin–deficient mice carrying
H-2
 
b
 
 haplotype (
 
b
 
2
 
0/0
 
; Jackson Laboratories, Bar Harbor, ME),
and B2L mice lacking the endogenous I-A
 
b
 
b
 
 chain, invariant
chain, and 
 
b
 
2-microglobulin were developed (B2L TKO). To
develop B2L TKO/2B4
 
b
 
 mice, we crossed B2L TKO with mice
transgenic for 2B4 TCR-
 
b
 
 chain that were maintained of
C57BL/6 (B6) background (H-2
 
b
 
) in our facility (33). 
 
b
 
2
 
0/0
 
/
2B4
 
b
 
 or E
 
a
 
-B6/2B4
 
b
 
 mice were developed by crossing TKO/
2B4
 
b
 
 mice with 
 
b
 
2
 
0/0
 
 or E
 
a
 
 transgenic B6 (E
 
a
 
-B6) mice (34),
respectively.
 
Antibodies.
 
The following mAbs were purchased from
PharMingen (San Diego, CA): FITC–anti-CD8 (53-6.7); PE–
anti-CD4 (RM4-5); biotinylated anti-NK1.1 (PK136); purified
anti-CD24 (HSA, J11D); FITC–anti-TCR V
 
a
 
2 (B20.1); V
 
a
 
3.2
(RR3-16); V
 
a
 
8 (B21.14); FITC–anti-TCR V
 
b
 
2 (B20.6); V
 
b
 
4
(KT4); V
 
b
 
5 (MR9-4); V
 
b
 
6 (RR4-7); V
 
b
 
7 (TR310); Vb8
(MR5-2); Vb9 (MR10-2); Vb10 (B21.5); Vb11 (RR3-15);
Vb12 (MR11-1); Vb13 (MR12-3); Vb14 (14-2); and biotiny-
lated anti-TCR Vb3 (KJ25). The mouse IgM mAb specific for
CD8 used for the killing experiments were purchased from Meiji
Institute of Health Science (Tokyo, Japan).
Flow Cytometry and Cell Sorting. Single cell suspensions of
thymocytes were prepared from mice 6–7 wk old and stained
with FITC-anti-CD8, PE–anti-CD4, and biotinylated anti-
NK1.1 or biotinylated anti-TCR Vb3 mAb followed by strepta-
vidin-Cy-Chrome (PharMingen). To assess the expression of
TCR Va or Vb on CD41CD82 thymocytes, thymocytes were
incubated with anti-CD8 and anti-HSA IgM mAbs, followed
by rabbit complement to remove immature thymocytes and
CD42CD81 thymocytes. Viable cells recovered using Lym-
pholyte-M (Cedarlane, Ontario, Canada) were stained with PE–
anti-CD4 and FITC–anti-TCR Va or Vb mAb, with or without
biotinylated anti-TCR Vb3 followed by streptavidin-Cy-Chrome.
Analyses were done on a FACScanÒ (Becton Dickinson, Moun-
tain View, CA). For cell sorting, CD41CD82 thymocytes were
enriched as described above and were stained with PE–anti-CD4
and FITC-anti-CD8, with or without biotinylated anti-TCR
Vb3 mAb followed by streptavidin-Cy-Chrome. CD41CD82 or
CD41CD82Vb3hi thymocytes (1–2 3 105) were sorted out using
EPICS ELITEÒ (Coulter Corp., Hialeah, FL) or FACSÒ Vantage
(Becton Dickinson) and were immediately placed in liquid nitro-
gen. All reagents were used at 10 mg/ml.
Mixed Lymphocyte Reaction. Lymph node CD41 T cells were
prepared by eliminating CD81 T cells and B cells from lymph
node cells using anti-CD8 antibody followed by immunomagnetic
beads coated with anti–Rat IgG antibody and those coated with
anti–mouse IgG antibody (both from DYNAL, Oslo, Norway).
The lymph node CD41 T cells (1 3 105 cells/well) were cultured
with irradiated spleen cells (1 3 106 cells/well) for 80 h and 1 mCi
of [3H]thymidine was added during 16 h of the culture.
Anchored PCR. The following oligonucleotides were used:
PCaF1,TTGGGAGTCAAAGTCGGTGAAC; Caout, AAC-
AGGCAGAGGGTGCTGTC; Cain, CTGAGACCGAGGA-
TCTTTTAAC; AP, GGCCACGCGTCGACTAGTACGGGI-
IGGGIIGG GIIG; AUAP, GGCCACGCGTCGACTAGTAC.
Total cellular RNA was extracted from the sorted thymocytes
using ISOGEN in the presence of 1 ml of Ethachinmate that fa-
cilitates the recovery of small amounts of nucleotides (both from
Nippon Gene, Tokyo, Japan). The first strand cDNA synthesis
1Abbreviations used in this paper: b20/0, mice lacking b2-microglobulin;
B2L or B2H, mouse lines expressing I-Abb chain covalently bound to
Ea52-68; B6, C57BL/6 mice; CLIP, invariant chain–derived class II–asso-
ciated peptide; DKO, mice lacking endogenous I-Abb and invariant
chains; Ea52-68, Ea-derived peptide; Ea-B6, C57BL/6 mice transgenic
for Ea; H-2M0/0, mice lacking H-2M expression; TKO, mice lacking en-
dogenous I-Abb, invariant chain, and b2-microglobulin; TKO/2B4b,
B2L TKO/2B4b, b20/0/2B4b, Ea-B6/2B4b; TKO, B2L TKO, b20/0
and Ea-B6 mice expressing 2B4 TCR-b chain.899 Fukui et al.
primed with TCR Ca-specific antisense oligonucleotide, PCaF1,
was carried out using SuperScriptÔ II reverse transcriptase
(GIBCO BRL, Gaithersburg, MD) at 508C. After treatment with
RNase H and RNase I at 378C for 30 min, the first strand cDNA
was purified from unincorporated dNTPs and PCaF1 and was
subjected to homopolymeric tailing using terminal deoxynucle-
otidyl transferase and dCTP. With this dC-tailed cDNA, several
PCR were carried out using Caout and AP primers, under the
following condition: 948C (2 min), 1 cycle; 948C (1 min), 558C
(1 min), and 728C (2 min), 30 cycles; 728C (5 min), 1 cycle.
Then, the first PCR products were mixed and subjected to the
second PCR using Cain and AUAP primers in the presence of
TaqStart antibody (CLONTECH Laboratories, Inc., Palo Alto,
CA), under the following condition: 948C (2 min), 1 cycle; 948C
(1 min), 578C (1 min), and 728C (2 min), 30 cycles; 728C (5
min), 1 cycle. When cDNA without dC-tailing was used, no vis-
ible band was obtained after the second PCR (data not shown).
Cloning and Sequencing of Anchored PCR Products. The mix-
ture of the second PCR products was ligated to pGMT-T Easy
Vector (Promega Corporation, Madison, WI) and was used for
the subsequent transformation of DH5a. Each colony was picked
up and cultured in LB medium (100 ml) at 378C for 5 h using 96-
well U bottom plates, then the supernatant was subjected to PCR
using AUAP and Cain2 (GAGACCGAGG ATCTTTTAACT)
primers, under the following condition: 948C (30 s), 1 cycle;
958C (30 s) 688C (3 min), 25 cycles. After removal of excess
primers and dNTPs using centricon 100 (Amicon, Inc., Beverly,
MA), the purified PCR products were labeled with dye termina-
tor cycle sequencing using Caseq primer (AGACCGAG-
GATCTTTTAACT) and were analyzed on an ABI PRISMÔ
377 DNA sequencer (Perkin-Elmer Corporation, Foster City,
CA) according to standard protocols.
Results
CD41 T Cell Differentiation Directed by the I-Ab–Ea52-68
Complex in Mice Lacking Endogenous MHC Class I and Class
II Expressions. Earlier, we had reported three lines of
transgenic mice that had been developed by introducing
the gene encoding I-Abb chain covalently bound to Ea52-
68 into mice lacking both endogenous I-Abb and invariant
chains (DKO; reference 24). Evidence that the I-Ab mole-
cule covalently bound to Ea52-68 is expressed in these
transgenic lines as a single species was obtained by complete
inhibition by the mAb specific for I-Ab–Ea52-68 complex
of staining with an anti–I-Ab reagent, the inability of trans-
genic spleen cells to present other I-Ab-binding peptides,
and the robust proliferative response of transgenic CD41 T
cells to wild-type I-Ab molecules with a normal array of
self-peptides (24). In addition, a similar transgenic mouse
line developed by Ignatowicz et al. (20) has been shown by
the detailed analysis to present no other detectable self-pep-
tides (26). However, we have found that CD41CD82 thy-
mocytes in these transgenic mice include NK1.11 thy-
mocytes that are selected by nonclassical MHC class I
molecules such as CD1 (35, 36). To purify CD41CD82
thymocytes selected to mature on I-Ab–Ea52-68 complex
from those selected by nonclassical and probably classical
MHC class I molecules, we introduced null mutation of
b2-microglobulin required for MHC class I expression into
B2L DKO mice that expressed I-Ab–Ea52-68 complex in
the thymus at an intermediate level and showed most effec-
tive CD41 T cell differentiation among three lines (24). Fi-
nally, B2L transgenic mice or nontransgenic mice lacking
endogenous I-Abb, invariant chain, and b2-microglobulin
(B2L TKO and TKO) were developed and used in the
present study.
Although no definite CD41CD82 thymocytes were ob-
served in TKO mice lacking MHC class I and class II ex-
pression, significant numbers of CD41CD82 thymocytes
were selected to mature on a single I-Ab–Ea52-68 com-
plex in B2L TKO, reaching a level of z25% of that seen in
mice that express wild-type I-Ab molecules but lack b2-
microglobulin expression (b20/0; Fig. 1 A). Although the
proportion of CD41CD82 thymocytes in B2L TKO was
comparable to that in B2L DKO, CD41CD8int thymocytes
markedly decreased in B2L TKO. Such a decrease, com-
pared with DKO or C57BL/6 (B6) mice, was also found in
TKO and b20/0 mice. These observations are consistent
with the previous report (37), supporting the model that
Figure 1. CD41 T cell differentiation in B2L TKO and B2L DKO
mice. (A) Thymocytes were prepared from six different lines (DKO, B2L
DKO, B6, TKO, B2L TKO, and b20/0) at 6–7 wk old and analyzed for
CD4 and CD8 expression. The percentages of CD4 1CD82,
CD41CD8int, CD41CD81, and CD42CD81 thymocytes are indicated.
The data represent at least three independent experiments. The mean 6
one SD for the percentage of CD41CD82 and CD41CD8int thymocytes
in each line are as follows: DKO, 0.7 6 0.1% and 1.9 6 0.1%; B2L
DKO, 2.0 6 0.4% and 2.5 6 0.4%; B6, 7.2 6 0.5% and 2.8 6 0.3%;
TKO, 0.4 6 0.1% and 0.3 6 0.0%; B2L TKO, 2.0 6 0.3% and 0.4 6
0.1%; b20/0, 8.3 6 0.5% and 1.7 6 0.0%. (B) The expression of NK1.1
on CD41CD82 thymocytes is compared between B2L DKO (left, dotted
line) and B2L TKO (left, solid line) or between B6 (right, dotted line) or b20/0
(right, solid line). The percentage of CD41CD82NK1.11 thymocytes in
mice with or without MHC class I expression are indicated above or be-
low the line, respectively. For each line, at least two mice were analyzed.
The each value for the percentage of CD41CD82NK1.11 thymocytes to
total CD41CD82 thymocytes was as follows: B2L DKO, 11.3, 7.9, 8.9;
B2L TKO, 0.4, 0.8, 0.7; B6, 1.6, 2.1; b20/0, 0.1, 0.1.900 Specific T Cell Receptor–Peptide Interaction in Positive Selection
CD41CD8int population represents developing thymocytes
to CD42CD81 phenotype as well as those to CD41CD82
phenotype (38). When NK1.1 expression was analyzed in
B2L DKO, around 10% of CD41CD82 thymocytes ex-
pressed this surface marker. However, as we expected,
CD41CD82NK1.11 T cells were scarcely observed in the
thymus from B2L TKO (Fig. 1 B).
CD41CD82 Thymocytes Selected to Mature on the I-Ab–
Ea52-68 Complex Express Diverse TCR-a Chains with No
Obvious Structural Features. In an attempt to assess the role
of self-peptides in shaping a mature T cell repertoire, we
first compared the TCR Vb usages in CD41CD82 thy-
mocytes from B2L TKO with those from b20/0 mice, using
a panel of mAbs. Although the proportions of CD41CD82
thymocytes expressing TCR Vb4, 12, and 14 slightly in-
creased in B2L TKO (Vb4, 12.7 6 0.5% vs. 8.3 6 0.3%;
Vb12, 3.7 6 0.5% vs. 2.7 6 0.1%; Vb14, 12.7 6 0.7% vs.
10.2 6 0.2%), other TCR Vb were similarly expressed on
CD41CD82 thymocytes in these lines (data not shown).
In contrast to the availability of the mAbs specific for
TCR Vb segments, only limited numbers of mAbs are
available for TCR Vas, some of which react with only the
subfamily of a particular TCR Va family. To overcome
this problem and thoroughly analyze the TCR-a reper-
toire, we sorted CD41CD82 thymocytes and examined
TCR-a mRNA using anchored PCR followed by se-
quencing of the cloned PCR products. From B2L TKO
CD41CD82 thymocytes, we obtained 97 clones originat-
ing from different templates, where 13 different Va fami-
lies and 27 different Ja segments were encoded. On the
other hand, we obtained from b20/0 CD41CD82 thy-
mocytes 71 independent TCR-a sequences that encoded
13 different Va families and 22 different Ja segments.
When the Va and Ja usages were compared, no remark-
able difference was observed (Fig. 2 A and data not shown).
The distribution of CDR3 length showed Gaussian-like
patterns in both cases (Fig. 2 B). In addition, no obvious
structural features in the CDR3 loops could be deduced,
even when clones from B2L TKO were analyzed (data not
shown). These results indicate that a single ligand, I-Ab–
Ea52-68 complex, selects a quite diverse T cell repertoire.
CD41 T Cell Differentiation Directed by the I-Ab–Ea52-68
Complex in the Presence of a Single Rearranged TCR-b
chain. The specificity of TCR for MHC–peptide ligands
is determined by both TCR-a and b chains. In light of the
low affinity interaction of TCR-a/b with MHC–peptide
ligands in positive selection (31), it would be difficult to vi-
sualize the imprint of selecting peptides on T cell repertoire
when TCR-a or TCR-b chains are separately analyzed,
even though selecting peptide is a single species. However,
some structural imprints might be revealed, if TCR-a or
TCR-b chains were to be analyzed for CD41CD82 thy-
mocytes expressing a particular TCR-b or TCR-a with
irrelevant specificity for the selecting ligand. To test this
idea, we employed the transgenic mice expressing 2B4
TCR-b (Vb3-Db1.1-Jb1.2) derived from the TCR-a/b
specific for moth cytochrome c peptide bound to I-Ek or I-Eb
molecules (7, 39), and, by crossing these mice with B2L
TKO, developed TKO mice expressing both B2L trans-
gene and the rearranged 2B4 TCR-b (B2L TKO/2B4b).
Although no CD41CD82 thymocytes were observed in
TKO/2B4b mice lacking MHC class I and class II expres-
sion, significant numbers of CD41CD82 thymocytes were
selected to mature in B2L TKO/2B4b and b20/0 mice ex-
pressing 2B4 TCR-b chain (b20/0/2B4b; Fig. 3 A). Lymph
node CD41 T cells from B2L TKO/2B4b mice as well as
B2L TKO responded well to spleen cells from b20/0 or
C57BL/6 (B6) mice expressing wild-type I-Ab molecules
with self-peptides other than Ea52-68, but did not show
any response to B2H TKO spleen cells that express I-Ab–
Ea52-68 complex as a single species at higher level than
those from B2L TKO (24; Fig. 3 B). Taken together, these
observations suggest that positive and negative selection oc-
curs normally in immature thymocytes expressing the es-
sentially fixed 2B4 TCR-b and randomly rearranged
TCR-a in B2L TKO/2B4b mice.
When the expression of TCR Vb3 was analyzed, 65–
75% of CD41CD82 thymocytes from both B2L TKO/
2B4b and b20/0/2B4b mice expressed on their cell surface
TCR Vb3 at a high level (Fig. 3 C). Considerable numbers
of CD41CD82Vb32 and CD41CD82Vb3int thymocytes
expressed TCR Vb8 that is most frequently observed in
CD41CD82 thymocytes from both B2L TKO and b20/0
mice (B2L TKO, 18.0 6 0.4%; b20/0, 18.2 6 0.5%),
whereas no definite expression of TCR Vb8 was detected
Figure 2. Va usage (A) and CDR3 length distribution (B) of TCR-a
repertoire shaped by the I-Ab–Ea52-68 complex. CD41CD82 thy-
mocytes were sorted from B2L TKO or b20/0 mice, and TCR-a tran-
scripts were analyzed using anchored PCR followed by sequencing of the
cloned PCR products. The results are shown as the percentages of clones
originating from different templates. The clones encoding undefined
TCR Va are indicated as U.D. in A. CDR3 length in (B) is indicated as
the number of amino acid residues between two amino acids downstream
from the conserved cysteine at position 90 in the V region and two amino
acids upstream from the conserved GXG motif (where G is glycine and X
is any amino acid) in the J region (64).901 Fukui et al.
on CD41CD82 thymocytes expressing TCR Vb3 at a
high level from both B2L TKO/2B4b and b20/0/2B4b
(Fig. 3 C). These observations indicate that allelic exclusion
by the transgenic 2B4 TCR-b is almost completed in
CD41CD82Vb3hi thymocytes and suggest that these thy-
mocytes exclusively express the transgene.
Highly Restricted Expression of TCR-a Chains on
CD41CD82 Thymocytes Selected to Mature on the I-Ab–
Ea52-68 Complex in the Presence of Transgenic 2B4 TCR-b.
With the strategy described above, we then compared
TCR-a chains expressed on CD41CD82Vb3hi thy-
mocytes from B2L TKO/2B4b with those from b20/0/
2B4b or B6 mice expressing both Ea and 2B4 TCR-b
chains (Ea-B6/2B4b). In two independent experiments
using different B2L TKO/2B4b mice, 73 out of 109 clones
(67%) originating from different templates were found to
encode the Va18 family, and 42% of the remaining (15 of
36 clones) encoded the Va segment (denoted as 17.A2)
that was not observed in samples from b20/0/2B4b mice
but identical to that on a T cell clone reported by Moha-
patra et al. (40; Fig. 4 A). In contrast to the results on B2L
TKO/2B4b mice, such restricted TCR Va usage was not
observed with clones obtained from Ea-B6/2B4b or b20/0/
2B4b mice expressing wild-type I-Ab molecules with or
without I-Ab–Ea52-68 complex, respectively, though the
TCR Va repertoire differed between these strains, proba-
bly because of the presence of I-Eb molecules in Ea-B6/
2B4b mice. When the length of their CDR3 loops was
compared, the distribution pattern in B2L TKO/2B4b
mice differed from those in b20/0/2B4b and Ea-B6/2B4b
(Fig. 4 B).
Having found that CD41CD82 thymocytes selected to
mature on I-Ab–Ea52-68 complex preferentially expressed
Va18 in the presence of the 2B4 TCR-b, we focused on
clones encoding this Va family and analyzed amino acid se-
quences of their CDR3 loops. Surprisingly, 70 of 73 clones
bearing Va18 from B2L TKO/2B4b mice encoded aspar-
tic or glutamic acid at the first position of their CDR3
loops (a93; Table 1). In contrast, only 9 of 20 clones bear-
ing Va18 from b20/0/2B4b encoded aspartic or glutamic
acid at a93, and 11 other clones encoded several amino
acid residues including tryptophan, alanine, arginine, proline,
valine, threonine, glycine, and leucine (Table 1). The Va18
family includes two subfamilies, AV18S1 and AV18S2, that
only differ by the amino acid residue at position 25:
AV18S1 encodes threonine at this position, whereas AV18S2
encodes lysine (41). Although the subfamily was not deter-
mined for 23 clones from B2L TKO/2B4b mice due to
shortness of the PCR products, 50 other clones encoded
AV18S2 and 48 clones of these encoded aspartic or
glutamic acid at a93. Because of the lack of complete in-
formation on the genomic sequence of AV18S2, we cannot
determine at this stage whether aspartic or glutamic acid at
this position is encoded by a germ line sequence or created
by a random nucleotide (N-region) addition. Nonetheless,
since the AV18S2-bearing TCR-a chains with various
amino acid residues at a93 were found in b20/0/2B4b, it is
suggested that, in B2L TKO/2B4b mice, there is a strong
Figure 3. Phenotypic and functional analysis for CD41 T cell differen-
tiation directed by the I-Ab–Ea52-68 complex in the presence of the 2B4
TCR-b chain. (A) Thymocytes were prepared from TKO/2B4b, B2L
TKO/2B4b, and b20/0/2B4b mice at 6–7 wk old and analyzed for CD4
and CD8 expression. The percentages of CD41CD82, CD41CD8int,
CD41CD81, CD42CD81 thymocytes are indicated. For each line, at
least three mice were analyzed. The each value for the percentage of
CD41CD82 thymocytes was as follows: TKO/2B4b, 0.1, 0.1, 0.1; B2L
TKO/2B4b, 1.3, 0.9, 0.7, 0.7; b20/0/2B4b, 2.6, 2.3, 2.7. (B) Lymph
node CD41 T cells from B2L TKO/2B4b or B2L TKO mice were cul-
tured with irradiated spleen cells from B2H TKO, B6, and b20/0 mice,
and [3H]thymidine incorporation was measured. The data indicate the
mean plus one SD of triplicate cultures. (C) Thymocytes were prepared
from B2L TKO/2B4b or b20/0/2B4b mice at 6–7 wk old, and the ex-
pression of TCR Vb3 was analyzed for gated CD41CD82 thymocytes
(top). The percentages of CD41CD82Vb32, CD41CD82Vb3int,
CD41CD82Vb3hi thymocytes are indicated. For each line, four or three
mice were analyzed. The each value for the percentage of CD41
CD82Vb3hi thymocytes was as follows: B2L TKO/2B4b, 64.7, 71.0,
65.2, 75.0; b20/0/2B4b, 69.3, 75.3, 70.8. The expression of TCR Vb8
on CD41CD82Vb3hi, CD41CD82Vb3int, CD41CD82Vb32 thymo-
cytes and the percentages of positive population are shown below.902 Specific T Cell Receptor–Peptide Interaction in Positive Selection
selection to conserve or introduce negatively charged
amino acid residues at this position to survive the thymic
selection directed by a single I-Ab–Ea52-68 ligand.
Since AV18S2 and Va17.A2 were the major Va gene
segments obtained from B2L TKO/2B4b, we compared
the NH2-terminal structure of these segments from the cys-
teine at position 90. As shown in Fig. 5 A, the predicted
amino acid sequences are highly conserved between these
Va gene segments (80.7%). The CDR1 and CDR2 loops
of TCR-a chains have been suggested to play an important
role in interactions with MHC class II/peptide ligand (42-
44). Although three amino acid substitutions are observed
in their CDR1 loops, the property of these amino acid res-
idues is relatively conserved and the CDR2 loops show no
differences between AV18S2 and Va17.A2. Thus, it is
concluded that Va17.A2 encodes the Va chain that would
be structurally related to that encoded by AV18S2. When
CDR3 loops were analyzed for 15 clones encoding
Va17.A2 from B2L TKO/2B4b mice, we again found that
11 clones encoded aspartic or glutamic acid at a93 (Fig. 5 B).
Discussion
In this study, we compared the TCR-a repertoire in
CD41CD82 thymocytes selected to mature on a single
I-Ab–Ea52-68 ligand with those selected by wild-type I-Ab
molecules with a normal array of self-peptides, in the pres-
ence or absence of a single rearranged TCR-b chain irrele-
vant to this selecting ligand, using anchored PCR followed
by sequencing of the PCR products. This method is based
on competitive PCR without using specific primers for
particular Va segments, so that PCR bias is minimized. In
addition, clones originating from different templates can be
distinguished by differences in the anchored position, even
when they encode the same TCR-a chains. Although the
frequencies of Va3 or Va8 usage in B2L TKO and b20/0
mice estimated using this approach were much higher than
frequencies assessed using the mAbs, RR3-16 or B21.14
(data not shown), this is likely the result of specificity of
these mAbs that react with only some of these subfamilies
(45, 46). On the other hand, the frequencies of Va2 usage
estimated by this approach in several mouse lines including
B2L TKO, b20/0, and B2L TKO/2B4b largely agreed with
frequencies observed with the flow cytometric analysis us-
ing the mAb, B20.1, that reacts with almost all subfamilies
(47; data not shown). Therefore, we conclude that hetero-
geneity of the anchored PCR products would reflect, to
some extent, the real diversity of TCR-a repertoire in
CD41CD82 thymocytes.
By introducing the 2B4 TCR-b chain with irrelevant
specificity for the I-Ab–Ea52-68 complex, CD41CD82
thymocytes selected to mature on this single ligand ex-
pressed highly restricted TCR-a chains encoding Va18 or
its related sequence and negatively charged amino acid
residues at a93 in their CDR3 loops. Taking into consid-
eration that multiple TCR-a rearrangements cease only
after positive selection (48, 49), a small number of clones
encoding TCR-a chains without such structural features
might represent nonselectable in-frame rearrangements
(50). Alternatively, these clones might be derived from a
trace of CD41CD82Vb3int thymocytes where allelic ex-
clusion by 2B4 TCR-b is not accomplished. Since such
structural features of TCR-a chain were not observed
with CD41CD82Vb3hi thymocytes selected to mature in
b20/0/2B4b mice expressing wild-type I-Ab molecules
with a normal array of self-peptides, it is clear that highly
restricted Va usage and amino acid residues at a93 in B2L
TKO/2B4b mice does not result from efficient pairing of
particular TCR-a chains with 2B4 TCR-b as was previ-
ously reported (51, 52), but rather from thymic selection
Figure 4. Va usage (A) and
CDR3 length distribution (B) of
TCR-a repertoire shaped by the
I-Ab–Ea52-68 complex in the
presence of 2B4 TCR-b chain.
CD41CD82Vb3hi thymocytes
were sorted from B2L TKO/
2B4b, b20/0/2B4b, or Ea-B6/
2B4b mice, and TCR-a tran-
scripts were analyzed, as de-
scribed for Fig. 2. The results are
shown as percentages of clones
originating from different tem-
plates. The closed and hatched
boxes represent clones obtained
from independent experiments
using different mice. The clones
encoding undefined Va are indi-
cated as U.D. in A.903 Fukui et al.
Table 1. Comparison of Va18-encoding TCR-a Chains between B2L TKO/2B4b and b20/0/2B4b Mice
B2L TKO/2B4bb 2 0/0/2B4b
observed number observed number
CDR3 loops subfamily
total
(n 5 73)
CDR3 loops subfamily
total
(n 5 20) sequence length Ja S1 S2 ND* sequence length Ja S1 S2 ND*
DSTQVVGQL
DWTQVVGQL
DDNMGYKL
DAVNMGYKL
DLGGYKV
DEGGYKV
DAGGYKV
DVGGYKV
EAGGYKV
ETGGYKV
DQGGRAL
DGGAGNKL
DRGSALGRL
YRGSALGRL
DNYNQGKL
DEYNQGKL
DSWYNQGKL
PTTASLGKL
DGYAQGL
DNYAQGL
DGQAQGL
DDYAQGL
DFYAQGL
YQYAQGL
DNNYAQGL
DANYAQGL
DHNYAQGL
DGNYAQGL
DDNYAQGL
DQNYAQGL
DADYAQGL
DGNNYAQGL
DDNTNTGKL
DTNAYKV
DDTNAYKV
DGSSGNKL
DAGNTGKL
DDPGNTGKL
DAYRTGNTGKL
DNAGAKL
DPYNNNAP
DVNNNNAP
9
9
8
9
7
7
7
7
7
7
7
8
9
9
8
8
9
9
7
7
7
7
7
7
8
8
8
8
8
8
8
9
9
7
8
8
8
9
11
7
8
8
5
5
8
8
10
10
10
10
10
10
12
14
15
15
18
18
18
19
20
20
20
20
20
20
20
20
20
20
20
20
20
20
21
23
23
25
30
30
30
32
35
35
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
0
1
1
1
2
2
1
0
1
0
1
1
0
1
4
1
0
1
1
0
3
3
1
6
1
1
0
1
1
1
0
1
2
1
3
1
0
0
0
0
0
0
1
0
0
0
1
1
0
2
0
1
0
0
1
0
6
0
1
1
0
1
1
0
0
0
0
1
1
0
1
0
1
0
0
1
0
0
1
1
1
1
1
1
1
1
1
1
3
3
1
2
1
1
1
1
1
1
10
1
1
2
1
1
4
3
1
6
1
2
1
1
2
1
1
1
2
2
3
1
1
DSGYNKY
WTGGYKV
EKTGGYKV
GAGNKL
EERGSALGRL
ASSGSWQL
TNTGKL
ETNAYKV
VATNAYKV
LDTNAYKV
DAGNNNRI
DGPSSNTNKV
PTGNTGKL
ASNNAGAKL
DASGGSNAKL
EDNNAP
DAQNF
RASSSFSKL
TEASSSFSKL
7
7
8
6
10
8
6
7
8
8
8
10
8
9
10
6
5
9
10
9
10
10
14
15
17
21
23
23
23
24
27
30
32
34
35
41
42
42
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
0
0
1
1
1
0
1
0
1
1
1
1
0
0
1
1
1
0
0
1
1
0
0
0
1
0
1
0
0
0
0
1
1
1
1
1
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
*The clone, of which Va18 subfamily was not determined because of its shortness is indicated as ND.904 Specific T Cell Receptor–Peptide Interaction in Positive Selection
directed by I-Ab–Ea52-68 complex. We cannot determine
at this stage whether aspartic or glutamic acid at a93 is de-
termined by the germ line sequence or created by the
N-region. However, it is suggested that both structural fea-
tures in the Va gene segment and amino acid residue at
a93 are independently required to survive thymic selection
by this single ligand, because other Va gene segments, in-
cluding AV10S6 that encodes aspartic acid at this position
in its germ line (41), are not preferentially expressed in
CD41 CD82Vb3hi thymocytes from B2L TKO/2B4b
mice and AV18S2-bearing clones from b20/0/2B4b mice
were found to encode various amino acid residues at this
position. We have shown that lymph node CD41 T cells
from B2L TKO/2B4b mice acquire immunological toler-
ance to the I-Ab–Ea52-68 complex, suggesting that the T
cell repertoire in this line is shaped through both positive
and negative selection directed by a I-Ab–Ea52-68 ligand.
This might raise the possibility that developing thymocytes
expressing TCR-a chains other than those with the partic-
ular Va segments and CDR3 loops are eliminated in B2L
TKO/2B4b mice through interaction with I-Ab–Ea52-68
complexes that are expressed in this line but not in b20/0/
2B4b mice. However, this possibility is unlikely, because
various TCR-a chains without such structural features
were found in CD41CD82Vb3hi thymocytes from Ea-
B6/2B4b mice where I-Ab–Ea52-68 complexes are ex-
pressed in the thymus, probably at higher level than that in
B2L TKO/2B4b (34). Therefore, it is suggested that the
structural features of TCR-a chains observed in B2L
TKO/2B4b mice are imprinted under the process of posi-
tive selection directed by I-Ab–Ea52-68 complex.
Several groups recently reported that antigen-specific T
cells selected by a given MHC–peptide complex express
somewhat different TCR from those in normal mice, sug-
gesting that selecting self-peptides influence mature T cell
repertoire (53–55). However, it is difficult from these ex-
periments to precisely determine whether the altered T cell
repertoire mainly results from positive selection directed by
a particular MHC–peptide ligand or antigen-driven expan-
sion of some T cells that would be deleted in normal mice
expressing the same MHC class II molecules at high level
in the thymus with a normal array of self-peptides, because
negative selection to wild-type MHC molecules was lack-
ing in some experiments (54) or was ineffective (53, 55).
This issue was clarified in this study where CD41CD82
thymocytes positively selected by a single I-Ab–Ea52-68
ligand were directly analyzed for TCR-a chains expressed
in association with 2B4 TCR-b. Our findings clearly indi-
cate that self-peptides involved in positive selection influ-
ence structure of the variable gene segment and CDR3
loops of the selected TCR repertoire. In some antigen-spe-
cific TCR recognition, the amino acid residue at a93 has
been functionally or structurally shown to be involved in
peptide contact (56, 57). Thus, the highly restricted amino
acid residue at this position of TCR-a chains in B2L
TKO/2B4b mice strongly suggests that specific TCR–
peptide contacts are also involved in positive selection di-
rected by I-Ab–Ea52-68 complex. Since expression of the
I-Ab–Ea52-68 complex was readily detected in the thymus
using a mAb specific for this complex (24), it is unlikely
that this contribution of Ea52-68 to positive selection in
B2L TKO/2B4b mice is due to an extremely low expres-
sion of I-Ab molecules, which might cause a more stringent
requirement of specific selecting peptides than that under
physiological conditions. In addition, CD41CD82 thy-
mocytes in B2L TKO/2B4b mice, different from studies
using TCR-a/b transgenic mice, are selected from the semi-
diverse T cell repertoire with randomly rearranged TCR-a
chains and the essentially fixed 2B4 TCR-b chain. Al-
though further analysis needs to address whether self-pep-
tides with amino acid residues bearing bulky or charged
side chains at positions facing TCR would mediate effi-
cient positive selection, our findings on B2L TKO/2B4b
mice provide definitive evidence that specific recognition
of self-peptides by TCR is involved in positive selection of
thymocytes and support the recent observation that the
amino acid composition of CDR3 loops analyzed for par-
ticular Vb-Jb segments in B2L DKO mice is slightly differ-
ent from those in B6 mice (58).
Figure 5. Predicted amino acid sequence of Va17.A2-encoding TCR-a
chains. (A) The NH2-terminal structure of Va17.A2 from cysteine at po-
sition 90 is compared with that of AV18S2. CDR1 and CDR2 are boxed.
(B) The clones originating from different templates were analyzed for
CDR3 loops and Ja gene segments.905 Fukui et al.
Studies on crystallography of two MHC class I–peptide
complexes with their associated TCR-a/b have revealed
that five CDs both from TCR-a and TCR-b chains, ex-
cept for TCR-b CDR2, directly interact with MHC class
I–peptide complex in a diagonal orientation (57, 59). Al-
though no structural data are available for the interaction of
TCR-a/b with MHC class II–peptide complex, functional
studies have suggested that a similar but not identical inter-
action also occurs in this case (43, 44). Since CDR1 and
CDR2 are determined by a variable segment itself, our
finding on B2L TKO/2B4b mice that developing thy-
mocytes expressing TCR-a chains with particular Va seg-
ments and CDR3 loops are allowed to mature on a single
MHC–peptide ligand suggests that at least two good fits are
required for the interaction of TCR-a/b with a selecting
ligand to survive positive selection. Despite this require-
ment, however, TCR-a chains expressed on CD41CD82
thymocytes from B2L TKO mice showed no obvious bias
in Va usage and amino acid composition of their CDR3
loops. By analyzing the affinity of TCR-a/b for positively
or negatively selecting MHC–peptide ligands in a cell-free
system, Alam et al. (31) have suggested that the affinity
window to survive both positive and negative selection is
quite narrow. Therefore, provided that a TCR-b chain has
CDR1 or CDR3 that fits with a selecting ligand, CDR of
the associated TCR-a chain on mature thymocytes would
be less characteristic, because not only of low affinity inter-
action sufficient for surviving positive selection but also of
negative selection of developing thymocytes expressing
TCR-a chains with good fits. Together with the degener-
acy in recognition of peptides by TCR-a/b (60), this could
explain why B2L TKO/2B4b mice but not B2L TKO show
structural features in their mature TCR-a repertoire. Al-
though the degree of this structural fitness for a selecting
MHC–peptide ligand would be affected by its cell surface
density in thymic cortex and medulla (17–19, 24, 61), the
partial fitness of TCR-a/b for their selecting peptide and/or
MHC molecule might be a general feature of the mature T
cell repertoire shaped by both positive and negative selection.
Although H-2M0/0 mice had been used to define the
role of particular self-peptides in positive selection (21–23,
25, 27), it has been shown that peptides other than CLIP
are bound to I-Ab molecules and contribute to the positive
selection of CD41 thymocytes (26). By comparing a partic-
ular Va-Ja segment in H-2M0/0 mice with that in H-2M0/1
in the presence of a single rearranged TCR-b chain,
Sant’Angelo et al. (30) recently reported that alteration of
self-peptides bound to I-Ab molecules affects CDR3 length
of the selected TCR-a repertoire. The somewhat biased
distribution of CDR3 length observed with the TCR-a
repertoire in B2L TKO/2B4b mice largely supports their
findings. However, it should be noted that homogeneity in
the CDR3 length in B2L TKO/2B4b mice depends on
the analyzed Va-Ja segments: 12 out of 12 clones encod-
ing Va17.A2-Ja15 have the same CDR3 length, whereas
this is not the case with the Va18-Ja20 segment where 16
clones have a CDR3 loop of 7 amino acids, 18 clones have
a CDR3 loop of 8 amino acids, and 1 clone has a CDR3
loop of 9 amino acids. Therefore, different from the case
with antigen-driven T cell expansion (62, 63), our findings
in B2L TKO/2B4b mice suggest that homogeneity in the
CDR3 length does not serve as a hallmark of specific
TCR–peptide interaction in the positive selection of thy-
mocytes. In addition, the TCR-a repertoire in B2L TKO/
2B4b mice, as compared with that in H-2M0/0 mice ex-
pressing the transgenic TCR-b chain, showed a stronger
restriction to amino acid residue in the CDR3 loops. This
would result from differences in the expression level of I-Ab
molecules in the thymus and/or the diversity of selecting
peptides, that is single or heterogeneous. Furthermore, the
difference in the introduced TCR-b chain might affect the
outcome, because D10 TCR-b chain used in their experi-
ment is derived from the I-Ab–reactive TCR-a/b (42).
In conclusion, we have shown that, by expression of a
single rearranged TCR-b chain with irrelevant specificity
for the selecting ligand, CD41CD82 thymocytes selected
to mature on a single MHC class II–peptide ligand express
highly restricted TCR-a chains in terms of Va usage and
amino acid residue of their CDR3 loops, thereby provid-
ing evidence for specific recognition of self-peptides by
TCR-a/b in positive selection. Thus, our experimental
system made it feasible to visualize TCR structure required
for surviving positive selection directed by a single MHC–
peptide ligand. This approach would lead to the relevant
application for elucidation of topology of TCR-MHC-
peptide interaction in positive selection.
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